Erratum: Prolonged Insulin Independence After Islet Allotransplants in Recipients with Type 1 Diabetes (American Journal of Transplantation (2008) 8(11) (2463–2470), (S1600613522030118), (10.1111/j.1600-6143.2008.02404.x));Prolonged insulin independence after islet allotransplants in recipients with type 1 diabetes

American Journal of Transplantation

Volumn 8, Issue 11, 2008, Pages 2463-2470

  Bellin, M D ^a   Kandaswamy, R ^a   Parkey, J ^a   Zhang, H J ^a   Liu, B ^a   Ihm, S H ^a   Ansite, J D ^a   Witson, J ^a   Bansal Pakala, P ^a   Balamurugan, A N ^a   Papas, K ^a   Sutherland, D E R ^a   Moran, A ^a   Hering, B J ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

Allograft survival; Everolimus; Islet graft; Islet transplantation; Islets; Thymoglobulin

Indexed keywords

ANTIINFECTIVE AGENT; BASILIXIMAB; C PEPTIDE; CYCLOSPORIN; DIPHENHYDRAMINE; ETANERCEPT; EVEROLIMUS; HEMOGLOBIN A1C; INSULIN; METHYLPREDNISOLONE; MYCOPHENOLIC ACID; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PARACETAMOL; PENTOXIFYLLINE; RAPAMYCIN; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; THYMOCYTE ANTIBODY; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ALLOIMMUNITY; ARTICLE; AUTOIMMUNITY; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEMALE; GINGIVA HYPERTROPHY; GLOMERULUS FILTRATION RATE; GRAFT VERSUS HOST REACTION; HUMAN; HYPOGLYCEMIA; IMMUNOSUPPRESSIVE TREATMENT; INSULIN DEPENDENT DIABETES MELLITUS; LOADING DRUG DOSE; MALE; NEPHROTOXICITY; PANCREAS ISLET TRANSPLANTATION; PRIORITY JOURNAL; TREATMENT OUTCOME;

EID: 53749089122     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2009.03000.x     Document Type: Erratum

References (20)

1. Shapiro AM, Lakey JR, Ryan EA et al. Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. N Engl J Med 2000 343 : 230 238.
2. Hering BJ, Kandaswamy R, Ansite JD et al. Single-donor, marginal-dose islet transplantation in patients with type 1 diabetes. JAMA 2005 293 : 830 835.
3. Shapiro AM, Ricordi C, Hering BJ et al. International trial of the Edmonton protocol for islet transplantation. N Engl J Med 2006 355 : 1318 1330.
4. Froud T, Ricordi C, Baidal DA et al. Islet transplantation in type 1 diabetes mellitus using cultured islets and steroid-free immunosuppression: Miami experience. Am J Transplant 2005 5 : 2037 2046.
5. Shapiro AM, Lakey JRT, Paty BW, Senior PA, Bigam DL, Ryan EA. Strategic opportunities in clinical islet transplantation. Transplantation 2005 79 : 1304 1307.
6. Ryan EA, Paty BW, Senior PA et al. Five-year follow-up after clinical islet transplantation. Diabetes 2005 54 : 2060 2069.
7. Monti P, Scirpoli M, Maffi P et al. Islet transplantation in patients with autoimmune diabetes induces homeostatic cytokines that expand autoreactive memory T cells. J Clin Invest 2008 118 : 1806 1814.
8. Nir T, Melton DA, Dor Y. Recovery from diabetes in mice by beta cell regeneration. J Clin Invest 2007 117 : 2553 2561.
9. Blondet JJ, Carlson AM, Kobayashi T et al. The role of total pancreatectomy and islet autotransplantation for chronic pancreatitis. Surg Clin North Am 2007 87 : 1477 1501.
10. Gores PF, Najarian JS, Stephanian E, Lloveras JJ, Kelley SL, Sutherland DE. Insulin independence in type I diabetes after transplantation of unpurified islets from single donor with 15-deoxyspergualin. Lancet 1993 341 : 19 21.
11. Warnock GL, Kneteman NM, Ryan E, Seelis RE, Rabinovitch A, Rajotte RV. Normoglycaemia after transplantation of freshly isolated and cryopreserved pancreatic islets in type 1 (insulin-dependent) diabetes mellitus. Diabetologia 1991 34 : 55 58.
12. Yu L, Robles DT, Abiru N et al. Early expression of antiinsulin autoantibodies of humans and the NOD mouse: Evidence for early determination of subsequent diabetes. Proc Natl Acad Sci USA 2000 97 : 1701 1706.
13. Yu L, Rewers M, Gianani R et al. Antiislet autoantibodies usually develop sequentially rather than simultaneously. J Clin Endocrinol Metab 1996 81 : 4264 4267.
14. Mohanakumar T, Narayanan K, Desai N et al. A significant role for histocompatibility in human islet transplantation. Transplantation 2006 82 : 180 187.
15. Pinkse GG, Tysma OH, Bergen CA et al. Autoreactive CD8 T cells associated with beta cell destruction in type 1 diabetes. Proc Natl Acad Sci USA 2005 102 : 18425 18430.
16. Fung MA, Warnock GL, Ao Z et al. The effect of medical therapy and islet cell transplantation on diabetic nephropathy: An interim report. Transplantation 2007 84 : 17 22.
17. Senior PA, Zeman M, Paty BW, Ryan EA, Shapiro AM. Changes in renal function after clinical islet transplantation: Four-year observational study. Am J Transplant 2007 7 : 91 98.
18. Keymeulen B, Ling Z, Gorus FK et al. Implantation of standardized beta-cell grafts in a liver segment of IDDM patients: Graft and recipient characteristics in two cases of insulin-independence under maintenance immunosuppression for prior kidney graft. Diabetologia 1998 41 : 452 459.
19. Maki T, Ichikawa T, Blanco R, Porter J. Long-term abrogation of autoimmune diabetes in nonobese diabetic mice by immunotherapy with anti-lymphocyte serum. Proc Natl Acad Sci USA 1992 89 : 3434 3438.
20. Pirsch JD, Miller J, Deierhoi MH, Vincenti F, Filo RS. A comparison of tacrolimus (FK506) and cyclosporine for immunosuppression after cadaveric renal transplantation. FK506 Kidney Transplant Study Group. Transplantation 1997 63 : 977 983.